Hong Kong stocks surged | In the morning, Ying En Biotech (09606.HK) rose by more than 8%, officially entering the Hong Kong Stock Connect list yesterday, the successful phase III study of HER2 ADC breast cancer.
According to the CITIC Securities APP, Ying En Biotechnology (09606.HK) surged over 8% in early trading, with a rise of 3.97% as of the time of publication, reaching HK$418.8, with a turnover of HK$133 million.
Latest
1 m ago
